R. Lizak - 14 Aug 2023 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Chief Financial Officer
Signature
/s/ Carol R. Lizak
Issuer symbol
JAGX
Transactions as of
14 Aug 2023
Transactions value $
$0
Form type
4
Filing time
14 Aug 2023, 17:48:05 UTC
Previous filing
19 May 2023
Next filing
17 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAGX Common Stock Award $0 +142K +21626.79% $0.00 143K 14 Aug 2023 Direct
holding JAGX Common Stock 7.97K 14 Aug 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.